Moreno Rodríguez, T., Monterde Martínez, B., González Silva, L., Betancor-Fernández, I., Revilla Gómez, C., Agraz Doblas, A. M., . . . Varela Egocheaga, I. (2021). ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Citación estilo ChicagoMoreno Rodríguez, Thaidy, et al. ARID2 Deficiency Promotes Tumor Progression and Is Associated With Higher Sensitivity to Chemotherapy in Lung Cancer. 2021.
Cita MLAMoreno Rodríguez, Thaidy, et al. ARID2 Deficiency Promotes Tumor Progression and Is Associated With Higher Sensitivity to Chemotherapy in Lung Cancer. 2021.
Precaución: Estas citas no son 100% exactas.